Salazopyrin (azulfidine) treatment in scleroderma.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D005260:Female; D006197:Hair / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009068:Movement / Q000187:drug effects; D010858:Pigmentation / Q000187:drug effects; D012594:Scleroderma, Localized / Q000188:drug therapy*; D012595:Scleroderma, Systemic / Q000188:drug therapy*; D012867:Skin / Q000187:drug effects; D012460:Sulfasalazine / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D012460:Sulfasalazine